517 related articles for article (PubMed ID: 28587234)
1. Peptidylarginine Deiminases-Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release?
Lange S; Gallagher M; Kholia S; Kosgodage US; Hristova M; Hardy J; Inal JM
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587234
[TBL] [Abstract][Full Text] [Related]
2. Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme.
Kosgodage US; Uysal-Onganer P; MacLatchy A; Kraev I; Chatterton NP; Nicholas AP; Inal JM; Lange S
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597867
[TBL] [Abstract][Full Text] [Related]
3. Post-translational protein deimination signatures in sea lamprey (Petromyzon marinus) plasma and plasma-extracellular vesicles.
Rast JP; D'Alessio S; Kraev I; Lange S
Dev Comp Immunol; 2021 Dec; 125():104225. PubMed ID: 34358577
[TBL] [Abstract][Full Text] [Related]
4. Chloramidine/Bisindolylmaleimide-I-Mediated Inhibition of Exosome and Microvesicle Release and Enhanced Efficacy of Cancer Chemotherapy.
Kosgodage US; Trindade RP; Thompson PR; Inal JM; Lange S
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486412
[TBL] [Abstract][Full Text] [Related]
5. Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson's Disease.
Sancandi M; Uysal-Onganer P; Kraev I; Mercer A; Lange S
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326590
[TBL] [Abstract][Full Text] [Related]
6. A Pilot Study on Peptidylarginine Deiminases and Protein Deimination in Animal Cancers across Vertebrate Species.
Inal JM; Hristova M; Lange S
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955829
[TBL] [Abstract][Full Text] [Related]
7. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer.
Kosgodage US; Mould R; Henley AB; Nunn AV; Guy GW; Thomas EL; Inal JM; Bell JD; Lange S
Front Pharmacol; 2018; 9():889. PubMed ID: 30150937
[TBL] [Abstract][Full Text] [Related]
9. Peptidylarginine deiminases and deiminated proteins at the epidermal barrier.
Cau L; Méchin MC; Simon M
Exp Dermatol; 2018 Aug; 27(8):852-858. PubMed ID: 29756256
[TBL] [Abstract][Full Text] [Related]
10. The Proteome and Citrullinome of
Magnadóttir B; Kraev I; Dodds AW; Lange S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467210
[TBL] [Abstract][Full Text] [Related]
11. A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy.
Kholia S; Jorfi S; Thompson PR; Causey CP; Nicholas AP; Inal JM; Lange S
J Extracell Vesicles; 2015; 4():26192. PubMed ID: 26095379
[TBL] [Abstract][Full Text] [Related]
12. Differential, Stage Dependent Detection of Peptidylarginine Deiminases and Protein Deimination in Lewy Body Diseases-Findings from a Pilot Study.
Mercer A; Jaunmuktane Z; Hristova M; Lange S
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361903
[TBL] [Abstract][Full Text] [Related]
13. Post-Translational Deimination of Immunological and Metabolic Protein Markers in Plasma and Extracellular Vesicles of Naked Mole-Rat (
Pamenter ME; Uysal-Onganer P; Huynh KW; Kraev I; Lange S
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671738
[TBL] [Abstract][Full Text] [Related]
14. Post-translational protein deimination signatures and extracellular vesicles (EVs) in the Atlantic horseshoe crab (Limulus polyphemus).
Bowden TJ; Kraev I; Lange S
Dev Comp Immunol; 2020 Sep; 110():103714. PubMed ID: 32335073
[TBL] [Abstract][Full Text] [Related]
15. Peptidylarginine deiminases and extracellular vesicles: prospective drug targets and biomarkers in central nervous system diseases and repair.
Lange S
Neural Regen Res; 2021 May; 16(5):934-938. PubMed ID: 33229732
[TBL] [Abstract][Full Text] [Related]
16. The emerging role of exosome and microvesicle- (EMV-) based cancer therapeutics and immunotherapy.
Moore C; Kosgodage U; Lange S; Inal JM
Int J Cancer; 2017 Aug; 141(3):428-436. PubMed ID: 28247946
[TBL] [Abstract][Full Text] [Related]
17. Peptidylarginine deiminase and deiminated proteins are detected throughout early halibut ontogeny - Complement components C3 and C4 are post-translationally deiminated in halibut (Hippoglossus hippoglossus L.).
Magnadóttir B; Bragason BT; Bricknell IR; Bowden T; Nicholas AP; Hristova M; Guðmundsdóttir S; Dodds AW; Lange S
Dev Comp Immunol; 2019 Mar; 92():1-19. PubMed ID: 30395876
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles from cod (Gadus morhua L.) mucus contain innate immune factors and deiminated protein cargo.
Magnadóttir B; Kraev I; Guðmundsdóttir S; Dodds AW; Lange S
Dev Comp Immunol; 2019 Oct; 99():103397. PubMed ID: 31108150
[TBL] [Abstract][Full Text] [Related]
19. Peptidylarginine Deiminase Inhibitors Reduce Bacterial Membrane Vesicle Release and Sensitize Bacteria to Antibiotic Treatment.
Kosgodage US; Matewele P; Mastroianni G; Kraev I; Brotherton D; Awamaria B; Nicholas AP; Lange S; Inal JM
Front Cell Infect Microbiol; 2019; 9():227. PubMed ID: 31316918
[TBL] [Abstract][Full Text] [Related]
20. Deimination Protein Profiles in
Criscitiello MF; Kraev I; Petersen LH; Lange S
Front Immunol; 2020; 11():651. PubMed ID: 32411128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]